One of the most prevalent diseases worldwide, breast cancer can strike both men and women, and its onset and spread are influenced by a variety of genetic variables. Researchers are discovering that no two cases of breast cancer are exactly the same as they continue to understand more about the molecular composition of the disease. As a result, a more individualized therapy strategy involving genomic analysis has been developed. By providing a more individualized treatment plan based on the unique features of each patient’s illness, genomic profiling is revolutionizing the way physicians treat breast cancer. Let’s examine how personalize medicine and better treatment results are being shaped by genetic profiling in breast cancer.
What is Genomic Profiling?
Genomic Profiling—also referred to as genetic testing or tumor sequencing—involves examining the DNA of the patient’s healthy cells as well as the cancer cells. When it comes to breast cancer, this profiling helps in determining the distinct features of the tumor, including molecular pathways that are propelling the growth of the disease, gene expression patterns, and genetic abnormalities. Doctors can better understand the behavior of cancer and select treatments that particularly target the mutations driving its growth by looking at the genetic composition of the disease.
For instance, the test for HER2 (human epidermal growth factor receptor 2), a protein that stimulates the growth of cancer cells, is one of the most well-known genetic tests used in breast cancer. Breast tumors that are HER2-positive typically develop more quickly and aggressively. But with the use of genomic analysis, medical professionals can find these tumors early and treat them with targeted treatments like trastuzumab (Herceptin), which targets HER2 selectively and lowers the chance of recurrence.
How Genomic Profiling Improves Targeted Treatment
The primary advantage of genetic profiling is that it makes tailored treatment possible, which is more accurate than conventional methods. Chemotherapy and other conventional breast cancer treatments target cells that divide quickly. Chemotherapy can harm healthy cells and cause side effects like fatigue, nausea, and hair loss, even though it is often effective. This is changed by genomic profiling, which assists doctors in concentrating on treatments that specifically target the genetic vulnerabilities of the cancer, resulting in a more effective course of treatment with fewer side effects.
